Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland 
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions 
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling 
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role 
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year 
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage 
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow 
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown 
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift 
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group 
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy 
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training 
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand 
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies 
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector 
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip 
Italy Fines Apple €98.6 Million Over App Store Dominance 
DRAPER, Utah, Oct. 20, 2016 -- HealthEquity, Inc. (NASDAQ:HQY) announced today the pricing of the previously announced secondary offering of shares of its common stock. Certain of HealthEquity's stockholders have agreed to sell an aggregate of 2,500,000 shares of the company's common stock in an underwritten public offering, which are being sold by the underwriters at a price to the public of $35.85 per share. The offering is expected to close on October 25, 2016, subject to customary closing conditions. Additionally, the selling stockholders have granted the underwriters a 30-day option to purchase up to an additional 375,000 shares of the company's common stock. HealthEquity will not receive any proceeds from the sale of the shares offered by the selling stockholders.
Jefferies LLC and Raymond James & Associates, Inc. are acting as joint book-running managers for the offering.
The shares are being offered pursuant to an effective shelf registration statement filed with the Securities and Exchange Commission (SEC). The offering is being made only by means of a prospectus supplement and accompanying prospectus. A preliminary prospectus supplement and accompanying prospectus relating to the offering have been filed with the SEC and are available on the SEC's website located at http://www.sec.gov. Copies of the preliminary prospectus supplement and accompanying prospectus relating to the offering, when available, may be obtained from Jefferies LLC, Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, 2nd Floor, New York, NY 10022, or by telephone at (877) 547-6340, or by email at [email protected]; or from Raymond James & Associates, Inc., Attention: Prospectus Department, 880 Carillon Parkway, St. Petersburg, FL 33716, or by telephone at (800) 248-8863, or by email at [email protected].
This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About HealthEquity
Founded in 2002, HealthEquity is one of the nation's largest health savings custodians. The Company's innovative technology platform and tax-advantaged accounts help members build health savings, while controlling health care costs. HealthEquity services more than 2.3 million health savings accounts for 80 health plan partners and employees at 33,000+ companies across the United States.
Investor Relations Contact: Richard Putnam 801-727-1209 [email protected]
